224 THE ENZYME TREATMENT OF CANCER
to be aimed at, and that, as William of Occam long ago laid down, Entia non sunt multiplicanda.
In the following lines something must be said of two aspects of the writer’s studies of pancreatic ferments and their uses. There are not many things in my research career which fill me with greater satisfaction than the line of reasoning and the conclusions as to the place of amylopsin in the enzyme treatment of cancer. Amylopsin itself, no matter what the doses be, will not cure cancer; but it cannot be dispensed with when pancreatic ferments, such as trypsin, are employed against malignant disease. If trypsin had been as successful hitherto in its mission in the treatment of cancer as amylopsin, there would be many living who are now departed, and the literature of medicine would contain fewer “scientific’ leaders upon “cancer booms.” Amylopsin was introduced into the enzyme treatment, not because of the discovery of any action upon cancer cells, and not because it was “thought ‘to digest’ the dead cancer cells” (Bainbridge’s Report, p. 6), but because the conclusion was reached, upon purely embryological grounds, that sufficiently potent injections of amylopsin would remove all the bad symptoms leading up to something identical with “ the vomiting of pregnancy” and with eclampsia itself, which had arisen in very many cases in England, Italy, France, and elsewhere. In the very first case in which it was “ tried,” as also in countless cases since that time, amylopsin always removed these symptoms. But it is a curious commentary upon what has been termed the “conservatism” of the medical profession, that although injections of this enzyme were recommended for the treatment of eclampsia, not a single case is known at present to the writer where this was employed. So much for the place of science in “ medical science.”